1. A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
- Author
-
Cem Akin, Theo Gülen, Jan Romantowski, Peter Valent, Knut Brockow, Michel Arock, Magdalena Lange, Bogusław Nedoszytko, Aleksandra Górska, Marta Gruchała-Niedoszytko, Marek Niedoszytko, Medical University of Gdańsk, Karolinska University Hospital [Stockholm], Karolinska Institutet [Stockholm], Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University of Michigan Medical School [Ann Arbor], University of Michigan [Ann Arbor], University of Michigan System-University of Michigan System, and Medizinische Universität Wien = Medical University of Vienna
- Subjects
0301 basic medicine ,Allergy ,Wasp Venoms ,Review ,medicine.disease_cause ,Pathogenesis ,lcsh:Chemistry ,0302 clinical medicine ,Allergen ,Vegetables ,Mast Cells ,[SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology ,lcsh:QH301-705.5 ,Spectroscopy ,mastocytosis ,Anti-Inflammatory Agents, Non-Steroidal ,MCAS ,Fishes ,General Medicine ,Syndrome ,Mast cell ,ddc ,3. Good health ,Computer Science Applications ,medicine.anatomical_structure ,hypersensitivity ,Anaphylaxis ,Food Hypersensitivity ,Diagnostic methods ,Catalysis ,Inorganic Chemistry ,Diagnosis, Differential ,03 medical and health sciences ,Allergists ,medicine ,anaphylaxis ,Animals ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,Anesthetics ,business.industry ,Organic Chemistry ,Allergens ,medicine.disease ,mast cell ,Hymenoptera ,Basophil activation ,030104 developmental biology ,030228 respiratory system ,lcsh:Biology (General) ,lcsh:QD1-999 ,Concomitant ,Fruit ,Immunology ,Tryptases ,business - Abstract
International audience; Primary and secondary mast cell activation syndromes (MCAS) can occur in patients with mastocytosis. During the past few years our knowledge about the pathogenesis and disease-triggering mechanisms in MCAS and mastocytosis have increased substantially. Whereas mastocytosis is characterized by an accumulation of neoplastic (clonal) mast cells (MC) in various organ systems, MCAS is defined by a massive and systemic activation of these cells. Mast cells are crucial effector cells in allergic diseases, thus their elevated number and activation can cause severe anaphylactic reactions and MCAS in patients with mastocytosis. However, these cells may also degranulate spontaneously or degranulate in response to non-allergic triggers leading to clinical symptoms. In mastocytosis patients, such symptoms may lead to the diagnosis of a primary MCAS. The diagnosis of a concomitant allergy in mastocytosis patients is challenging. In these patients, a mixed form (primary and secondary) of MCAS may be diagnosed. These patients may also suffer from life-threatening anaphylactic reactions when exposed to allergens. In these cases, the possibility of severe side effects of in vivo provocations can sometimes also limit diagnostic evaluations. In the current article, we discuss the diagnosis and management of patients suffering from mastocytosis and concomitant MCAS, with special emphasis on novel diagnostic tests and management, including allergen microarrays, recombinant allergen analysis, basophil activation tests, optimal prophylaxis, and specific therapies
- Published
- 2021